![Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease](https://www.ti.ubc.ca/wordpress/wp-content//uploads/2013/01/87-fig1.jpg)
Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease
![Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9eedbe38927fda118d3f7368ad657b72bc2a49f/2-Table1-1.png)
Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar
![Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT](https://www.arzneimitteltherapie.de/_Resources/Persistent/8/b/1/9/8b19b93cb7a7a159801aeef75ff97af9398b1c39/lipp-rosuvastatin_01_converted_eps.png)
Auswahl von Statinen vor dem Hintergrund neu verfasster Lipidleitlinien - 04 - 2020 - Heftarchiv - AMT
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-02.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.001.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort | PLOS ONE
![A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health](https://www.liebertpub.com/cms/10.1089/jwh.2015.5271/asset/images/medium/figure1.gif)
A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health
![In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413120303168-fx1.jpg)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - ScienceDirect
![Statins in Chronic Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations | National Lipid Association Online Statins in Chronic Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations | National Lipid Association Online](https://www.lipid.org/sites/default/files/images/Table%201%20Lerma.jpg)
Statins in Chronic Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations | National Lipid Association Online
Fractional Flow Reserve-Guided SYNTAX Score for Risk Assessment in Multi-vessel Coronary Artery Disease
![Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer | British Journal of Cancer Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2014.283/MediaObjects/41416_2014_Article_BFbjc2014283_Fig1_HTML.jpg)
Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer | British Journal of Cancer
![Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37efcaf1312c5ca35047d184682c7857630cce38/4-Table1-1.png)
Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar
![Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study - Farnier - 2009 - International Journal Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study - Farnier - 2009 - International Journal](https://onlinelibrary.wiley.com/cms/asset/9956d93b-0850-441c-998c-f24abd326214/ijcp_2022_f1.gif)